MENU

TMO Stock Thermo Fisher Scientific (TMO, $448.94) was a top loser this week, declining -5.94%

A.I.dvisor
at Tickeron.com
Loading...
TMO - Thermo Fisher Scientific
Tickeron

Loading...

Price: $448.94
Daily change: -$17.48 (-3.75%)
Daily volume: 2.5M
Weekly price change: -$28.34 (-5.94%)
Capitalization: $176.1B
Industry: Medical Specialties
Thermo Fisher Scientific (TMO, $448.94) was a top weekly loser, falling to $448.94 per share. Of the 90 stocks analyzed in the Medical Specialties Industry throughout the week of July 30 - August 6, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.

TMO's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for TMO moved out of overbought territory on July 30, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 instances where the indicator moved out of the overbought zone. In of the 41 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TMO as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TMO turned negative on August 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TMO broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

TMO moved above its 50-day moving average on July 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TMO advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 288 cases where TMO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TMO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.445) is normal, around the industry mean (8.160). P/E Ratio (26.647) is within average values for comparable stocks, (132.856). Projected Growth (PEG Ratio) (1.878) is also within normal values, averaging (1.738). Dividend Yield (0.004) settles around the average of (0.025) among similar stocks. P/S Ratio (4.057) is also within normal values, averaging (7.877).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TMO showed earnings on July 23, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of analytical and environment monitoring instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
168 Third Avenue
Phone
+1 781 622-1000
Employees
122000
Web
https://www.thermofisher.com